Edition:
United States

Valeant Pharmaceuticals International Inc (VRX.TO)

VRX.TO on Toronto Stock Exchange

25.36CAD
8 Dec 2017
Change (% chg)

$2.68 (+11.82%)
Prev Close
$22.68
Open
$22.89
Day's High
$25.44
Day's Low
$22.84
Volume
4,484,701
Avg. Vol
1,565,309
52-wk High
$25.44
52-wk Low
$11.20

Chart for

About

Valeant Pharmaceuticals International, Inc. is a pharmaceutical and medical device company. The Company is engaged in developing and marketing a range of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products, and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment,... (more)

Overall

Beta: -0.27
Market Cap(Mil.): $6,876.81
Shares Outstanding(Mil.): 348.26
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.13 15.67
EPS (TTM): -- -- --
ROI: -- 15.10 34.62
ROE: -- 16.59 16.00

BRIEF-Valeant Announces Pricing Of Private Offering Of Senior Notes

Dec 4 Valeant Pharmaceuticals International Inc :

Dec 04 2017

BRIEF-Valeant, Unit Announce Upsize of Cash Tender Offers

Dec 4 Valeant Pharmaceuticals International Inc :

Dec 04 2017

BRIEF-Valeant Announces Launch Of Private Offering Of Senior Notes

Dec 4 Valeant Pharmaceuticals International Inc :

Dec 04 2017

BRIEF-Valeant announces closing of add-on secured notes and credit agreement amendment

* Valeant announces closing of add-on secured notes and credit agreement amendment Source text for Eikon: Further company coverage:

Nov 21 2017

BRIEF-Valeant announces pricing of private offering of add-on secured notes

* Valeant announces pricing of private offering of add-on secured notes

Nov 14 2017

BRIEF-Valeant announces launch of private offering of add-on secured notes

* Valeant announces launch of private offering of add-on secured notes

Nov 13 2017

BRIEF-Valeant Pharmaceuticals amends existing credit agreement

Nov 9 Valeant Pharmaceuticals International Inc :

Nov 09 2017

CANADA STOCKS-TSX adds to record highs as Valeant shares surge

TORONTO, Nov 7 Canada's main stock index added to its record highs on Tuesday, boosted by a jump in the shares of Valeant Pharmaceuticals International Inc after the company's earnings beat estimates, while some energy shares also climbed.

Nov 07 2017

Competitors

Earnings vs. Estimates